200 related articles for article (PubMed ID: 17965644)
1. Radioactive iodine therapy in poorly differentiated thyroid cancer.
Tuttle RM; Grewal RK; Larson SM
Nat Clin Pract Oncol; 2007 Nov; 4(11):665-8. PubMed ID: 17965644
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
[TBL] [Abstract][Full Text] [Related]
4. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
[TBL] [Abstract][Full Text] [Related]
5. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
[TBL] [Abstract][Full Text] [Related]
6. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
7. Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma.
Ilgan S; Karacalioglu AO; Pabuscu Y; Atac GK; Arslan N; Ozturk E; Gunalp B; Ozguven MA
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):825-30. PubMed ID: 14762699
[TBL] [Abstract][Full Text] [Related]
8. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors.
Song HJ; Qiu ZL; Shen CT; Wei WJ; Luo QY
Eur J Endocrinol; 2015 Sep; 173(3):399-408. PubMed ID: 26104753
[TBL] [Abstract][Full Text] [Related]
10. [Iodine uptake in the chest in the follow-up of well-differentiated thyroid cancer].
García Alonso MP; Balsa Bretón MA; Paniagua Correa C; Castillejos Rodríguez L; Penín González FJ; Elviro Peña R; Ortega Valle A; Mariana Monguía A; Vásquez Tineo SI; Mendoza Paulini A; Pey Illera C
Rev Esp Med Nucl; 2011; 30(1):24-8. PubMed ID: 20863596
[TBL] [Abstract][Full Text] [Related]
11. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
[No Abstract] [Full Text] [Related]
12. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
13. Post I-131 therapy scanning in patients with thyroid carcinoma metastases: an unnecessary cost or a relevant contribution?
Souza Rosário PW; Barroso AL; Rezende LL; Padrão EL; Fagundes TA; Penna GC; Purisch S
Clin Nucl Med; 2004 Dec; 29(12):795-8. PubMed ID: 15545881
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
15. Our experience from radioiodine-131 treatment and whole body scintigraphy findings in 357 patients with metastatic differentiated thyroid carcinoma after surgical ablation.
Kraft O; Reznák I
Hell J Nucl Med; 2006; 9(2):112. PubMed ID: 16894419
[No Abstract] [Full Text] [Related]
16. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
Salvatori M; Biondi B; Rufini V
Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
[TBL] [Abstract][Full Text] [Related]
18. The role of radioactive iodine in the treatment of Hürthle cell carcinoma of the thyroid.
Besic N; Vidergar-Kralj B; Frkovic-Grazio S; Movrin-Stanovnik T; Auersperg M
Thyroid; 2003 Jun; 13(6):577-84. PubMed ID: 12930602
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
20. [Differentiated thyroid gland carcinoma in a scintigraphically hot thyroid nodule: diagnosis and interdisciplinary therapeutic management].
Stahl A; Hess U; Harms J; Zwicknagl M; Langhammer H
Wien Klin Wochenschr; 2002 Jun; 114(10-11):410-4. PubMed ID: 12708097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
